Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

North Carolina State Capitol Raleigh

North Carolina seeks to become 1 of last states to license rad techs

It is 1 of only 5 states with no standards or licensing structure for rad techs and radiation therapists, advocates wrote in a recently published op-ed.

TV

Report: Former TV writer exploiting ACA to sell bare-bones insurance plans

Bloomberg writes about a company, Quick Health, run by a former comedy writer, who through a loophole in the law is accused of "hiring" members for fake jobs to enroll them in junk insurance policies.

Congress Money washington DC legislation coverage payment

Republicans in Congress back off proposal to cut Medicaid

House Speaker Mike Johnson confirmed on Tuesday that Medicaid cuts would be excluded from an upcoming spending bill, as both President Donald Trump and other Republicans in Congress opposed any reduction to funding. 

artificial intelligence AI in healthcare

Researchers identify ‘universal determinants of AI acceptance’ among healthcare workers

What attributes tend to nudge clinicians toward accepting AI into their work lives? Several, of course—but the most broadly determinative can be trimmed to just two. 

Tariffs not enough to make Siemens Healthineers move production or raise prices—yet

The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday. 
 

ACR updates guidance for managing and preventing contrast media reactions

The new recommendations address discordance between the college and other organizations’ prior guidelines on the use of premedication.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 

Prescription drugs pharmacy law

Michigan sues PBMs, alleging unlawful collusion created ‘pharmacy deserts'

State Attorney General Dana Nessel is suing Express Scripts and Prime Therapeutics, accusing the two PBMs of manipulating rebate pricing, "crippling small, independent pharmacies and restricting access to lifesaving medications in the process."